Anavex Life Sciences
AVXL
AVXL
153 hedge funds and large institutions have $245M invested in Anavex Life Sciences in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.49% more ownership
Funds ownership: 30.58% → 32.07% (+1.5%)
47% less call options, than puts
Call options by funds: $11.6M | Put options by funds: $21.9M
Holders
153
Holding in Top 10
–
Calls
$11.6M
Puts
$21.9M
Top Buyers
| 1 | +$5.89M | |
| 2 | +$5.68M | |
| 3 | +$2.56M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$967K |
Top Sellers
| 1 | -$6.49M | |
| 2 | -$2.81M | |
| 3 | -$1.02M | |
| 4 |
Two Sigma Investments
New York
|
-$768K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$405K |